Carbamazepine/denosumab/levetiracetam

Hypocalcaemia, vitamin D deficiency and secondary hyperparathyroidism: case report

    Reactions Weekly volume 1838, page128(2021)Cite this article

    This is a preview of subscription content, access via your institution.

    Access options

    Buy single article

    Instant access to the full article PDF.

    US$ 49.95

    Tax calculation will be finalised during checkout.

    Reference

    1. Zavratnik A, et al. Life threatening symptomat ichypocalcaemia triggered with denosumab in patient treated with chronic antiepileptic therapy. Osteoporosis International 30 (Suppl.): S379 (plus poster) abstr. P366, Jan 2019. Available from: URL: http://doi.org/10.1007/s00198-019-04993-w [abstract]

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Carbamazepine/denosumab/levetiracetam. Reactions Weekly 1838, 128 (2021). https://doi.org/10.1007/s40278-021-89447-3

    Download citation